Benzinga
17 Dec 2025, 16:26 UTC · 39w ago
Verdict
Headline takes no side. We score CURA +0.90 across four claims — strongly bullish.
+0.90strongly bullish
More positive than 94% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
President Donald Trump is poised to sign an executive order rescheduling marijuana from Schedule I to Schedule III.
More positive than 99% of claims this week
Rescheduling to Schedule III would lift the IRS Section 280E tax burden, which currently pushes cannabis operators' effective tax rates above 70%.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 99% of claims this week
Cannabis stocks rallied on above-average trading volumes as investors awaited an official statement from the President.
More positive than 91% of claims this week
Schedule III rescheduling does not fully legalize marijuana, meaning federal criminal penalties and conflicts with state laws will persist.
More negative than 81% of claims this week
Which stocks this story touches
More positive than 94% of ticker scores this week
Executive chairman explicitly called the rescheduling a 'game-changer' for the company.
More positive than 86% of ticker scores this week
Positive outlook due to potential rescheduling of cannabis to Schedule III and removal of tax burdens.
More positive than 86% of ticker scores this week
Positive outlook due to potential rescheduling of cannabis to Schedule III and removal of tax burdens.
More positive than 86% of ticker scores this week
Positive outlook due to potential rescheduling of cannabis to Schedule III and removal of tax burdens.
More positive than 86% of ticker scores this week
The ETF tracks a sector seeing a rally and optimism over the removal of IRS Section 280E.
More positive than 86% of ticker scores this week
Positive outlook due to potential rescheduling of cannabis to Schedule III and removal of tax burdens.
More positive than 86% of ticker scores this week
Positive outlook due to potential rescheduling of cannabis to Schedule III and removal of tax burdens.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
3d ago
Seeking Alpha
2d ago
More positive than 35% of relationship scores this week
[mutual] Both are identified as cannabis sector stocks responding to the same regulatory news.
More positive than 35% of relationship scores this week
[mutual] Both are identified as cannabis sector stocks responding to the same regulatory news.
More positive than 35% of relationship scores this week
[mutual] Both are identified as cannabis sector stocks responding to the same regulatory news.
More positive than 35% of relationship scores this week
[mutual] Both are identified as cannabis sector stocks responding to the same regulatory news.
More positive than 35% of relationship scores this week
[mutual] Both are identified as cannabis sector stocks responding to the same regulatory news.
More positive than 35% of relationship scores this week
[mutual] Both are identified as cannabis sector stocks responding to the same regulatory news.
More positive than 35% of relationship scores this week
[mutual] Both are identified as cannabis sector stocks responding to the same regulatory news.
More positive than 35% of relationship scores this week
[mutual] Both are identified as cannabis sector stocks responding to the same regulatory news.
More positive than 35% of relationship scores this week
[mutual] Both are identified as cannabis sector stocks responding to the same regulatory news.
—
No price for CURA right now — the quote feed didn't answer.
CURA chart →
